Page last updated: 2024-09-04

chs 828 and gne-618

chs 828 has been researched along with gne-618 in 1 studies

Compound Research Comparison

Studies
(chs 828)
Trials
(chs 828)
Recent Studies (post-2010)
(chs 828)
Studies
(gne-618)
Trials
(gne-618)
Recent Studies (post-2010) (gne-618)
21017909

Protein Interaction Comparison

ProteinTaxonomychs 828 (IC50)gne-618 (IC50)
Cytochrome P450 1A2Homo sapiens (human)0.004
Cytochrome P450 3A4Homo sapiens (human)0.004
Cytochrome P450 2C9 Homo sapiens (human)0.004
Cytochrome P450 2C19Homo sapiens (human)0.004
Nicotinamide phosphoribosyltransferaseHomo sapiens (human)0.0054
Nicotinamide phosphoribosyltransferase Rattus norvegicus (Norway rat)0.035
Nicotinamide phosphoribosyltransferaseMus musculus (house mouse)0.059

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bair, KW; Dragovich, PS; Ho, YC; Hua, R; Liederer, BM; Liu, X; O'Brien, T; Oeh, J; Patel, S; Sampath, D; Skelton, N; Sodhi, J; Wang, W; Wang, Y; Xiao, Y; Yuen, PW; Zak, M; Zhang, L; Zhao, G; Zheng, X1

Other Studies

1 other study(ies) available for chs 828 and gne-618

ArticleYear
Minimizing CYP2C9 Inhibition of Exposed-Pyridine NAMPT (Nicotinamide Phosphoribosyltransferase) Inhibitors.
    Journal of medicinal chemistry, 2016, 09-22, Volume: 59, Issue:18

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2C9 Inhibitors; Drug Discovery; Enzyme Inhibitors; Female; Humans; Mice; Mice, Nude; Models, Molecular; Neoplasms; Nicotinamide Phosphoribosyltransferase; Pyridines

2016